RAGONESE, Marta
 Distribuzione geografica
Continente #
EU - Europa 2.110
NA - Nord America 1.836
AS - Asia 1.224
SA - Sud America 456
AF - Africa 39
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.668
Nazione #
US - Stati Uniti d'America 1.793
RU - Federazione Russa 831
SG - Singapore 525
BR - Brasile 407
CN - Cina 359
IE - Irlanda 305
SE - Svezia 275
IT - Italia 226
HK - Hong Kong 154
DE - Germania 116
GB - Regno Unito 86
PL - Polonia 68
FI - Finlandia 54
VN - Vietnam 54
FR - Francia 43
UA - Ucraina 32
IN - India 29
AT - Austria 24
AR - Argentina 20
CA - Canada 18
JP - Giappone 18
MX - Messico 18
IQ - Iraq 16
ID - Indonesia 12
NL - Olanda 12
ZA - Sudafrica 12
BD - Bangladesh 10
CO - Colombia 10
ES - Italia 10
TR - Turchia 10
PK - Pakistan 7
BE - Belgio 6
KE - Kenya 5
PE - Perù 5
UZ - Uzbekistan 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
VE - Venezuela 4
EC - Ecuador 3
EE - Estonia 3
JO - Giordania 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
PH - Filippine 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IL - Israele 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.668
Città #
Moscow 396
Ashburn 324
Dublin 304
Singapore 267
Dallas 240
Chandler 194
Nyköping 173
Hong Kong 152
Beijing 144
Messina 111
Jacksonville 75
The Dalles 70
Munich 67
Warsaw 67
Los Angeles 64
New York 58
Princeton 43
Medford 42
São Paulo 40
Lancaster 39
Dearborn 35
Cambridge 29
Des Moines 25
Tianjin 24
Buffalo 22
Vienna 19
Ann Arbor 18
Redondo Beach 18
Shenyang 18
Boardman 17
Brooklyn 17
Helsinki 17
Tokyo 15
Seattle 14
Wilmington 12
Hanoi 11
Ho Chi Minh City 11
Jinan 11
London 11
Nanjing 11
Rio de Janeiro 11
Belo Horizonte 10
Brasília 10
Frankfurt am Main 10
Hyderabad 10
Pune 10
Rome 9
Baghdad 8
Catania 8
Council Bluffs 8
Denver 8
Guangzhou 8
Jakarta 8
Johannesburg 8
Nanchang 8
San Mateo 8
Turku 8
Düsseldorf 7
Lauterbourg 7
Manchester 7
Mexico City 7
Boston 6
Campinas 6
Dong Ket 6
Haikou 6
Hangzhou 6
Lappeenranta 6
Nuremberg 6
Santa Clara 6
Stockholm 6
Woodbridge 6
Atlanta 5
Bogotá 5
Chennai 5
Curitiba 5
Joinville 5
Montreal 5
Nairobi 5
Phoenix 5
Poplar 5
São Gonçalo 5
Tashkent 5
Toronto 5
Abidjan 4
Amsterdam 4
Ankara 4
Aracaju 4
Bexley 4
Biên Hòa 4
Bremen 4
Brussels 4
Changsha 4
Chicago 4
Columbus 4
Houston 4
João Pessoa 4
Ningbo 4
Orem 4
Palmas 4
Parma 4
Totale 3.591
Nome #
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 196
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 167
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 156
A case of clinically silent acromegaly with erectile dysfunction. 155
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 150
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 144
Increased prevalence of acromegaly in a highly polluted area. 142
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 141
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 140
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 138
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 131
Predictive markers of recurrence in radically resected pituitary macroadenomas 129
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 126
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 124
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 122
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 122
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 121
Effects of cyberknife radiotherapy treatment of pituitary adenomas 121
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 119
Course of pregnancies in women with Cushing's disease treated by gamma-knife 119
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 118
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 116
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 115
Thyroid nodules in growth hormone replaced patients. 114
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 111
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 109
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 107
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 105
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 103
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 102
Preconception Thyrotropin Levels and Thyroid Function at Early Gestation in Women with Hashimoto's Thyroiditis 100
How to improve effectiveness of pegvisomant treatment in acromegalic patients 97
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 93
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 92
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 89
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 84
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 84
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 84
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 83
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 80
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 79
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 79
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 74
Valutazione della morfologia e funzionalità tiroidea in pazienti acromegalici 73
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 70
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 69
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 66
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 66
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 61
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 60
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 60
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 58
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 56
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 53
Polychlorinated biphenyls (PCBs) modulate AHR pathways leading to the altered expression of genes involved in extra-cellular matrix (ECM) remodeling and epigenetic regulation in thyrocytes 50
null 35
null 27
Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients 25
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 17
Totale 5.827
Categoria #
all - tutte 20.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 36 12 24 21 15 9 12
2021/2022305 0 58 5 13 7 5 9 17 3 52 38 98
2022/2023865 81 87 47 48 44 82 31 27 358 8 43 9
2023/2024292 20 44 15 28 29 70 9 29 0 13 2 33
2024/20251.403 21 32 57 83 99 43 47 276 293 98 132 222
2025/20262.273 224 241 282 252 362 912 0 0 0 0 0 0
Totale 5.827